FER Regulates Endosomal Recycling and Is a Predictor for Adjuvant Taxane Benefit in Breast Cancer

The authors showed that high feline sarcoma-related non-receptor tyrosine kinase (FER) levels were also associated with improved outcomes after adjuvant taxane-based combination chemotherapy in high-risk, HER2-negative patients.
[Cell Reports]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News